MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0048203
Unicorn Pharmachem Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹9.36 Cr
▼ 48% YoY
Net profit · FY 2024
₹4.77 Lakh
Net margin 0.5%
EBITDA · FY 2024
₹25.57 Lakh
EBITDA margin 2.7%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹3.59 Cr
Issued & subscribed
Open charges
₹7.1 Cr
Secured borrowings
Company age
21 yrs
Est. 2005
Directors on board
6
As per MCA filings
About Unicorn Pharmachem Private Limited
Data last updated:
Unicorn Pharmachem Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 July 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC154558. Its GSTIN is 27AAACU7678K1ZN (Maharashtra).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹3.59 Cr. It is led by directors including Raj Mohan Appalacharya Nallan Chakravarty and Vijay Indravadan Dave.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.36 Cr, a decline of 48% compared to the previous year. For the same year it recorded a net profit of ₹4.77 Lakh (net margin 0.5%) and EBITDA of ₹25.57 Lakh (EBITDA margin 2.7%). Revenue has declined at a compounded annual rate (CAGR) of 20% over three years and 22% over five years.
Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Unicorn Pharmachem. As per MCA filings, the company has open charges of ₹7.1 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
Unicorn Pharmachem Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0048203). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unicornpharmachem.com.
Company details
CIN U24230MH2005PTC154558
Registration Number 154558
Incorporation Date 07 July 2005
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0048203
Key People
Raj Mohan Appalacharya Nallan Chakravarty Director Vijay Indravadan Dave Director Bhavesh Vallabhdas Shah Director Recognitions & Rankings of Unicorn Pharmachem
Contact details
Unicorn Pharmachem Private Limited's registered office is in Mumbai, Maharashtra. Its website is unicornpharmachem.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address302 Laxmi Villa Appt. M G Rd., Opp. Kala Hanuman Temple, Mumbai, Maharashtra, India – 400067
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Unicorn Pharmachem Private Limited, buy the company report.
Comprehensive company report
Unicorn Pharmachem Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Unicorn Pharmachem operates one associated brand: Unicorn Pharmachem. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Operates as a CDMO specializing in pharmaceutical intermediates manufacturing. | unicornpharmachem.com |
Business activity
The main business activity of Unicorn Pharmachem is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Unicorn Pharmachem Private Limited, buy the company report.
Financials of Unicorn Pharmachem Private Limited
FY 2024 filings availableUnicorn Pharmachem Private Limited reported revenue of ₹9.36 Cr (down 48% YoY) for FY 2024.
Revenue · FY 2024
₹9.36 Cr ▼ 48%
Net profit · FY 2024
₹4.77 Lakh margin 0.5%
EBITDA · FY 2024
₹25.57 Lakh margin 2.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 48%
3 years · compounded
▼ 20%
5 years · compounded
▼ 22%
EBITDA CAGR growth
1 year
▼ 79%
3 years · compounded
▼ 30%
5 years · compounded
▼ 16%
Revenue has declined at a compounded annual rate (CAGR) of 22% over five years, including a 48% fall in the latest year. EBITDA fell 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25.57 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.77 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unicorn Pharmachem Private Limited, buy the company report.
Board of directors of Unicorn Pharmachem Private Limited
Unicorn Pharmachem has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Mohan Appalacharya Nallan Chakravarty Also directs: Amtec Life Sciences Private Limited, Amtec Health Care Private Limited, Ullanat Estates Private Limited and 2 more | Director | 16 Feb 2008 | 18 Years 8 Months | Current |
| Vijay Indravadan Dave Also directs: Draco Lifesciences Private Limited | Director | 16 Feb 2008 | 18 Years 8 Months | Current |
| Bhavesh Vallabhdas Shah Also directs: Draco Lifesciences Private Limited | Director | 07 Jul 2005 | 21 Years 4 Months | Current |
| Jatin Vallabhdas Shah | Director | 07 Jul 2005 | 21 Years 4 Months | Current |
| Kamal Surya Patcha | Director | 07 Jul 2005 | 21 Years 4 Months | Current |
| Haridasan Raman | Director | 07 Jul 2005 | 21 Years 4 Months | Current |
Auditor
Unicorn Pharmachem Private Limited is audited by ASHOK PANDIT & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHOK PANDIT & CO. | FY 2023 | 100674W |
Shareholding
The shareholding of Unicorn Pharmachem Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Unicorn Pharmachem Private Limited, buy the company report.
Charges & borrowings
Open charges
₹7.1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 May 2011 | 10291935 | The Saraswat Co-Operative Bank Ltd | ₹1.1 Cr | Open | |
| 12 Mar 2010 | 10212228 | Others | ₹6 Cr | Open |
To see the full charge records of Unicorn Pharmachem Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Unicorn Pharmachem Private Limited has 1 court case on record: 1 filed by Unicorn Pharmachem. All case is pending.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Filed by the company against Union of India and 8 Ors. | Pending |
To see the full case history of Unicorn Pharmachem Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unicorn Pharmachem Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Unicorn Pharmachem has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Draco Lifesciences Private Limited | U24233MH2011PTC222207 |
To see the full group structure of Unicorn Pharmachem Private Limited, buy the company report.
GST
Unicorn Pharmachem has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACU7678K1ZN | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Unicorn Pharmachem Private Limited, buy the company report.
Recent activity
Unicorn Pharmachem Private Limited has 8 board changes on record since 2005: 6 appointments and 2 cessations. The latest: Raj Mohan Appalacharya Nallan Chakravarty ceased to be Additional Director on 30 Sep 2008.
AGM
Unicorn Pharmachem Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Unicorn Pharmachem Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Others of Rs. 6.00 Cr registered on 12 Mar 2010 with Charge ID 10212228 was modified on 06 Oct 2022.
Charges
A charge with The Saraswat Co-Operative Bank Ltd amounted to Rs. 1.10 Cr with Charge ID 10291935 was registered on 27 May 2011.
Charges
A charge with Others amounted to Rs. 6.00 Cr with Charge ID 10212228 was registered on 12 Mar 2010.
Ceased
Raj Mohan Appalacharya Nallan Chakravarty ceased to be Additional Director.
Ceased
Vijay Indravadan Dave ceased to be Additional Director.
Appointed
Raj Mohan Appalacharya Nallan Chakravarty was appointed as Director.
Appointed
Vijay Indravadan Dave was appointed as Director.
Appointed
Bhavesh Vallabhdas Shah was appointed as Director.
Appointed
Haridasan Raman was appointed as Director.
Appointed
Jatin Vallabhdas Shah was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Unicorn Pharmachem is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 July 2005 (21+ years old) and is registered under CIN U24230MH2005PTC154558.
Unicorn Pharmachem has 6 current directors:
- Raj Mohan Appalacharya Nallan Chakravarty - Director
- Vijay Indravadan Dave - Director
- Bhavesh Vallabhdas Shah - Director
- Jatin Vallabhdas Shah - Director
- Kamal Surya Patcha - Director
- Haridasan Raman - Director
The latest financial statements of Unicorn Pharmachem on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Unicorn Pharmachem is 27AAACU7678K1ZN, registered in Maharashtra.
The CIN (Corporate Identification Number) of Unicorn Pharmachem is U24230MH2005PTC154558. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unicorn Pharmachem has 1 court case on record: 1 filed by the company. 1 is pending.
Unicorn Pharmachem was incorporated on 07 July 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Raj Mohan Appalacharya Nallan Chakravarty ceased to be Additional Director on 30 Sep 2008. Vijay Indravadan Dave ceased to be Additional Director on 30 Sep 2008. Raj Mohan Appalacharya Nallan Chakravarty was appointed as Director on 16 Feb 2008. Unicorn Pharmachem has 8 board changes on record in total.
Yes, Unicorn Pharmachem is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0048203).
Unicorn Pharmachem can be reached through the website unicornpharmachem.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages